Goldstein David M
Insider CIK 1751719 · PRNB Chief Scientific Officer · ALMS Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALMS ALUMIS INC. | S Sale | 2026-08-03 | 2026-08-05 | 2,596 | $26.37 | $68.5K | 30,970 | SEC↗ |
| ALMS ALUMIS INC. | S Sale | 2026-08-03 | 2026-08-05 | 2,596 | $26.37 | $68.5K | 30,970 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2026-01-26 | 2026-01-28 | 216,675 | — | $0 | 216,675 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-07-29 | 2025-07-31 | 107,950 | — | $0 | 107,950 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2025-07-29 | 2025-07-31 | 27,000 | — | $0 | 29,115 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-02-18 | 2025-02-20 | 180,000 | — | $0 | 180,000 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 171,122 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 171,122 | — | $0 | 171,122 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 11,978 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 11,978 | — | $0 | 11,978 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 30,642 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 42,780 | — | $0 | 42,780 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 30,642 | — | $0 | 30,642 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 206,074 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 206,074 | — | $0 | 206,074 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 42,780 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 53,475 | — | $0 | 53,475 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 53,475 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer | 2024-07-01 | 2024-07-01 | 213,903 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2024-07-01 | 2024-07-01 | 213,903 | — | $0 | 213,903 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer | 2024-07-01 | 2024-07-01 | 2,994 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2024-07-01 | 2024-07-01 | 2,994 | — | $0 | 2,994 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 60,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 75,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 44,034 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 34,677 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 12,960 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 13,210 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 8,807 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 15,412 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 22,017 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 31,826 | $100.00 | $3.18M | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-08-10 | 2020-08-12 | 3,553 | — | $0 | 12,960 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-08-10 | 2020-08-12 | 2,447 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-08-10 | 2020-08-12 | 858 | $86.11 | $73.9K | 36,881 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-08-10 | 2020-08-12 | 3,553 | $3.18 | $11.3K | 37,739 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-08-10 | 2020-08-12 | 2,447 | $3.00 | $7.3K | 34,186 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-08-10 | 2020-08-12 | 100 | $93.34 | $9.3K | 31,739 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-08-10 | 2020-08-12 | 1,108 | $90.99 | $100.8K | 31,839 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-08-10 | 2020-08-12 | 700 | $89.68 | $62.8K | 32,947 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-08-10 | 2020-08-12 | 2,534 | $88.40 | $224.0K | 33,647 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-08-10 | 2020-08-12 | 700 | $86.92 | $60.8K | 36,181 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-05-07 | 2020-05-08 | 6,000 | — | $0 | 2,447 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-05-07 | 2020-05-08 | 6,000 | $3.00 | $18.0K | 36,968 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-05-07 | 2020-05-08 | 3,281 | $59.96 | $196.7K | 33,687 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-05-07 | 2020-05-08 | 2,719 | $60.39 | $164.2K | 30,968 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2020-03-05 | 2020-03-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-02-10 | 2020-02-12 | 6,000 | — | $0 | 8,447 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-02-10 | 2020-02-12 | 5,200 | $71.11 | $369.8K | 30,968 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-02-10 | 2020-02-12 | 800 | $69.53 | $55.6K | 36,168 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-02-10 | 2020-02-12 | 6,000 | $3.00 | $18.0K | 36,968 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2019-11-07 | 2019-11-08 | 1,127 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2019-11-07 | 2019-11-08 | 6,147 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2019-11-07 | 2019-11-08 | 1,651 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2019-11-07 | 2019-11-08 | 1,075 | — | $0 | 14,447 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2019-11-07 | 2019-11-08 | 1,075 | $3.00 | $3.2K | 39,819 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2019-11-07 | 2019-11-08 | 6,147 | $1.91 | $11.7K | 37,093 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-11-07 | 2019-11-08 | 10,000 | $32.39 | $323.9K | 29,819 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2019-11-07 | 2019-11-08 | 1,651 | $1.91 | $3.2K | 38,744 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2019-11-07 | 2019-11-08 | 1,127 | $0.64 | $721 | 30,946 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-03-01 | 2019-03-08 | 60,000 | — | $0 | 60,000 | SEC↗ |